Fatal sepsis months after bladder instillations with Mycobacterium bovis in patient with SARS-CoV-2 infection

Autor: F Ferrer Amate, Emilio Guirao-Arrabal, J Hernández-Quero, P M García-Ceberino

Publikováno v: Revista Española de Quimioterapia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b754867dd19760d8c9dfe97ffd11fee
https://doi.org/10.37201/req/095.2021

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Concomitant tuberculosis and lung cancer diagnosed by bronchoscopy

Autor: C Morales-García, A E Delgado-Martín, J Hernández-Quero, J Parra-Ruiz, J A Sánchez-Martínez, A Amzouz-Amzouz

Publikováno v: The International Journal of Tuberculosis and Lung Disease. 19:1027-1032

Setting South Granada Health Area (SGHA), Spain. Objective To describe the characteristics of concomitant tuberculosis (TB) and lung cancer cases. Design A total of 319 TB cases diagnosed between January 2003 and December 2010 were evaluated and iden

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5e83eb78413fe3c5c92ca44e6591c6
https://doi.org/10.5588/ijtld.14.0578

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study

Autor: E, Poveda, J, Hernández-Quero, M J, Pérez-Elías, M A, Ribas, O J, Martínez-Madrid, J, Flores, J, Navarro, F, Gutiérrez, M, García-Deltoro, A, Imaz, A, Ocampo, A, Artero, F, Blanco, E, Bernal, J, Pasquau, C, Mínguez-Gallego, N, Pérez, A, Aiestaran, F, García, R, Paredes, Coral García, Valdecillos

Publikováno v: HIV MEDICINE
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
HIV Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

Objectives Maraviroc (MVC) is a suitable drug for aviraemic subjects on antiretroviral treatment (ART) developing toxicity. Its prescription requires prior tropism testing. It is unknown if proviral DNA genotypic tropism testing is reliable for guidi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8eb9a3086ea3bc997a995fdba77ef36
https://pubmed.ncbi.nlm.nih.gov/28035758